Could a novel drug target improve survival rates for patients with pulmonary hypertension?
Researchers have identified the gene FOXM1 as a promising target for the treatment of pulmonary hypertension, hoping to design drugs to reverse the vascular remodeling seen in these patients.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.